azathioprine has been researched along with DDD MPGNII in 15 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To suppress the activity of glomerulonephritis, lupus and primary chronic mixed one, 13 children received plasmapheresis synchronously with pulse therapy with cyclophosphamide or prednisolone." | 5.07 | [Synchronization of plasmapheresis and pulse therapy in the complex treatment of children with highly active glomerulonephritis]. ( Donov, GI; Fomenko, TM; Kartasheva, VI; Klimov, IuV; Osminina, MK, 1991) |
| "Of these, alveolar hemorrhage is the most common and well-described hemorrhagic complication and is a prominent component of the pulmonary-renal syndrome." | 2.52 | Hemorrhagic complications associated with PR3-ANCA crescentic glomerulonephritis. ( Cao, Y; Li, W; Tian, Z; Wang, G; Yang, Y, 2015) |
| "The renal biopsy showed type I membranoproliferative glomerulonephritis." | 1.36 | Membranoproliferative glomerulonephritis following allogeneic hematopoietic stem cell transplantation. ( Chang, YS; Chung, S; Kim, B; Kim, JY; Lee, MY; Park, CW, 2010) |
| "Mixed Connective Tissue Disorder with Castleman's Disease is a rare association; the patient presenting with varied and interesting manifestations." | 1.36 | Mixed connective tissue disorder and Castleman's disease. ( Boorugu, HK; Chrispal, A; Thomas, EM; Vasuki, Z, 2010) |
| "Seven patients with type III membranoproliferative glomerulonephritis (MPGN) were followed for 9-17 years." | 1.31 | Long-term follow-up of type III membranoproliferative glomerulonephritis in children. ( Iitaka, K; Moriya, S; Nakamura, S; Sakai, T; Tomonaga, K, 2002) |
| "The renal survival of 53 MPGN patients treated on a long-term basis by non-steroid anti-inflammatory drugs (NSAID) was compared to that of untreated MPGN patients previously reported in the literature." | 1.27 | Renal survival in membranoproliferative glomerulonephritis (MPGN): role of long-term treatment with non-steroid anti-inflammatory drugs (NSAID). ( Belghiti, D; Lagrue, G; Laurent, J, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y | 1 |
| Tian, Z | 1 |
| Li, W | 1 |
| Yang, Y | 1 |
| Wang, G | 1 |
| Muinuddin, G | 1 |
| Paul, SK | 1 |
| Rahman, MH | 1 |
| Jahan, S | 1 |
| Begum, A | 1 |
| Salam, MA | 1 |
| Hossain, MM | 1 |
| Sahin, G | 1 |
| Korkmaz, C | 1 |
| Işiksoy, S | 1 |
| Yalçin, AU | 1 |
| Caltik, A | 1 |
| Demircin, G | 1 |
| Bülbül, M | 1 |
| Erdogan, O | 1 |
| Akyüz, SG | 1 |
| Arda, N | 1 |
| Kim, JY | 1 |
| Lee, MY | 1 |
| Kim, B | 1 |
| Park, CW | 1 |
| Chang, YS | 1 |
| Chung, S | 1 |
| Chrispal, A | 1 |
| Vasuki, Z | 1 |
| Thomas, EM | 1 |
| Boorugu, HK | 1 |
| Frappier, J | 1 |
| Legendre, C | 1 |
| Soria-Royer, C | 1 |
| Barbanel, C | 1 |
| Kreis, H | 1 |
| Beaune, P | 1 |
| Chan, TM | 1 |
| Cheng, IK | 1 |
| Wong, KL | 1 |
| Chan, KW | 1 |
| Klein, M | 1 |
| Radhakrishnan, J | 1 |
| Appel, G | 1 |
| Iitaka, K | 1 |
| Moriya, S | 1 |
| Nakamura, S | 1 |
| Tomonaga, K | 1 |
| Sakai, T | 1 |
| Jardim, HM | 1 |
| Leake, J | 1 |
| Risdon, RA | 1 |
| Barratt, TM | 1 |
| Dillon, MJ | 1 |
| Kartasheva, VI | 1 |
| Donov, GI | 1 |
| Fomenko, TM | 1 |
| Klimov, IuV | 1 |
| Osminina, MK | 1 |
| Zach, R | 1 |
| Roob, JM | 1 |
| Horn, S | 1 |
| Kaufmann, P | 1 |
| Winkler, HM | 1 |
| Holzer, H | 1 |
| Tilz, GP | 1 |
| Pogglitsch, H | 1 |
| Pap, I | 1 |
| Gärtner, U | 1 |
| Lagrue, G | 1 |
| Laurent, J | 1 |
| Belghiti, D | 1 |
2 reviews available for azathioprine and DDD MPGNII
| Article | Year |
|---|---|
Hemorrhagic complications associated with PR3-ANCA crescentic glomerulonephritis.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytopla | 2015 |
Cyclosporine treatment of glomerular diseases.
Topics: Autoimmune Diseases; Azathioprine; Cyclosporine; Drug Combinations; Glomerulonephritis; Glomerulonep | 1999 |
1 trial available for azathioprine and DDD MPGNII
| Article | Year |
|---|---|
[Synchronization of plasmapheresis and pulse therapy in the complex treatment of children with highly active glomerulonephritis].
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Chronic Disease; Combined Modality Therapy; Cyclo | 1991 |
12 other studies available for azathioprine and DDD MPGNII
| Article | Year |
|---|---|
A case of renal transplantation.
Topics: Adolescent; Antihypertensive Agents; Azathioprine; Child; Cyclophosphamide; Glomerulonephritis, Memb | 2008 |
Autoimmune hypothyroidism and lupus-like syndrome.
Topics: Adult; Arthritis; Azathioprine; Biphenyl Compounds; Complement C3; Complement C4; Complement System | 2010 |
An unusual case of ANA negative systemic lupus erythematosus presented with vasculitis, long-standing serositis and full-house nephropathy.
Topics: Administration, Oral; Adolescent; Antibodies, Antinuclear; Azathioprine; Cyclophosphamide; Dipyridam | 2013 |
Membranoproliferative glomerulonephritis following allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Azathioprine; Glomerulonephritis, Membranoproliferative; Graft vs Host Disease; Hematopoietic | 2010 |
Mixed connective tissue disorder and Castleman's disease.
Topics: Adolescent; Azathioprine; Biopsy; Castleman Disease; Female; Glomerulonephritis, Membranoproliferati | 2010 |
[Homozygote deficiency of thiopurine methyltransferase. A contraindication to the use of azathioprine in kidney transplantation].
Topics: Azathioprine; Contraindications; Female; Glomerulonephritis, Membranoproliferative; Graft Rejection; | 1995 |
Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castleman's disease).
Topics: Adult; Azathioprine; Biopsy; Castleman Disease; Complement System Proteins; Cyclophosphamide; Drug T | 1993 |
Long-term follow-up of type III membranoproliferative glomerulonephritis in children.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Child, Preschool; Compleme | 2002 |
Crescentic glomerulonephritis in children.
Topics: Adolescent; Adrenal Cortex Hormones; Anticoagulants; Azathioprine; Child; Child, Preschool; Cyclopho | 1992 |
[Clinical experiences with Wegener's granulomatosis from the nephrologic viewpoint].
Topics: Adolescent; Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cytoplasm; D | 1991 |
[Development of hypertension in patients with mesangioproliferative glomerulonephritis].
Topics: Adolescent; Adult; Azathioprine; Bacteriuria; Blood Pressure; Erythrocyte Count; Female; Follow-Up S | 1988 |
Renal survival in membranoproliferative glomerulonephritis (MPGN): role of long-term treatment with non-steroid anti-inflammatory drugs (NSAID).
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chlorambucil; Creati | 1988 |